Pacific Biosciences of California PACB Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $14.76M-38.0% | $23.78M-27.2% | $32.68M+328% | $7.64M+8,113% | ||
| —— | —— | —— | -$301K-457% | ||
| -$546.38M-75.0% | -$312.22M-1.8% | -$306.74M+2.4% | -$314.25M-73.4% | ||
| $4.18M+319% | $998K-71.0% | $3.44M-7.3% | $3.71M— | ||
| $364.54M+1,925% | $18.01M+192% | $6.16M— | —— | ||
| —— | —— | —— | —— | ||
| $369.45M+1,248% | $27.41M+345% | $6.16M— | $0— | ||
| -$18.7M-2,100% | -$850K-106% | $15.06M+534% | $2.38M+108% | ||
| $12.99M-5.7% | $13.77M+20.2% | $11.46M+20.9% | $9.48M+31.7% | ||
| —— | —— | —— | —— | ||
| $0-100% | $154.41M— | $0— | $0— | ||
| $15M— | —— | $0— | $0— | ||
| $2.48M— | —— | —— | —— | ||
| —— | —— | —— | -$5.46M-176% | ||
| $3.16M— | —— | $13.1M— | —— | ||
| —— | —— | —— | $33.91M+159% | ||
| -$8.51M— | —— | $9.79M-25.7% | $13.17M— | ||
| $8.26M-44.2% | $14.81M-5.6% | $15.69M+11.7% | $14.05M+103% | ||
| —— | -$42.99M— | —— | $9.62M-99.2% | ||
| $115.45M-6.9% | $124M— | —— | $116.08M+116% | ||
| -$111.21M+46.0% | -$206.06M+20.5% | -$259.17M+1.5% | -$263.21M-137% | ||
| —— | $0— | $0-100% | $179K— | ||
| $216.91M-56.5% | $498.64M-34.1% | $756.57M+70.9% | $442.79M-55.2% | ||
| $2.8M— | —— | $8.84M-47.2% | $16.75M+182% | ||
| $340.07M-42.7% | $593.97M-22.8% | $769.52M+33.6% | $575.8M+36.3% | ||
| $41.67M-41.3% | $71.04M-1.5% | $72.12M-8.3% | $78.61M+7.2% | ||
| -$171.43M+60.4% | -$433.13M-37.6% | -$314.74M-6.0% | -$296.8M-46.3% | ||
| -$553.86M-16.8% | -$474.31M-41.8% | -$334.47M-8.9% | -$307.2M-46.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pacific Biosciences of California's revenue?
- Pacific Biosciences of California (PACB) generated $160.0M in revenue over the trailing twelve months, up 5.0% year over year.
- Is Pacific Biosciences of California profitable?
- Pacific Biosciences of California is not currently profitable: it reported a net loss of $128.6M over the trailing twelve months, a -80.3% net margin.
- What are Pacific Biosciences of California's profit margins?
- Gross margin is 37.5% and operating margin is -83.3%, with a -80.3% net margin.
- What is Pacific Biosciences of California's earnings per share?
- Pacific Biosciences of California's diluted EPS over the trailing twelve months is $-0.43.
- Where does Pacific Biosciences of California's income statement data come from?
- Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
